FdaApplication
NDA 022203
Identifiers
- fda_app_no: NDA022203
Properties
| Property | Value |
|---|---|
| applicant_name | VIATRIS SPECIALTY LLC |
| application_type | NDA |
| approval_date | 2008-10-15 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ASTEPRO | AZELASTINE HYDROCHLORIDE | 0.137MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SPRAY, METERED;NASAL |
| ASTEPRO | AZELASTINE HYDROCHLORIDE | 0.2055MG/SPRAY | SPRAY, METERED;NASAL |
2 products